Ivabradine use as an antiarrhythmic therapy in congenital junctional ectopic tachycardias

2018 ◽  
Vol 41 (11) ◽  
pp. 1576-1576 ◽  
Author(s):  
Yakup Ergul ◽  
Erkut Ozturk
Keyword(s):  
Antiarrhythmic Therapy

scholarly journals Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year.

Circulation ◽  
1987 ◽  
Vol 75 (4) ◽  
pp. 792-799 ◽  
Author(s):  
S H Gottlieb ◽  
S C Achuff ◽  
E D Mellits ◽  
G Gerstenblith ◽  
K L Baughman ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
High Risk ◽  
Antiarrhythmic Therapy ◽  
Lower Mortality

scholarly journals Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery disease

1990 ◽  
Vol 65 (18) ◽  
pp. 1192-1197 ◽  
Author(s):  
Ali R. Moosvi ◽  
Sidney Goldstein ◽  
Sharon VanderBrug Medendorp ◽  
J.Richard Landis ◽  
Robert A. Wolfe ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Cardiac Arrest ◽  
Coronary Artery ◽  
Antiarrhythmic Therapy ◽  
Artery Disease ◽  
Hospital Cardiac Arrest

Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias

1988 ◽  
Vol 62 (12) ◽  
pp. H39-H45 ◽  
Author(s):  
Dennis L. Kuchar ◽  
Hasan Garan ◽  
Jeremy N. Ruskin
Keyword(s):  
Antiarrhythmic Therapy ◽  
Ventricular Tachyarrhythmias

Efficacy of Propafenone When Used in Combination Antiarrhythmic Therapy

1987 ◽  
Vol 1 (6) ◽  
pp. 575-579 ◽  
Author(s):  
RICHARD C. KLEIN ◽  
FRANK I. MARCUS
Keyword(s):  
Antiarrhythmic Therapy

scholarly journals Preliminary Study of Coupling Intervals of Premature Ventricular Complexes in Dogs With Different Cardiac Diseases

2021 ◽  
Author(s):  
Liza Sally Koster ◽  
Jonathan Abbott
Keyword(s):  
Heart Disease ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Structural Heart Disease ◽  
Holter Monitoring ◽  
Antiarrhythmic Therapy ◽  
Premature Ventricular Complex ◽  
Coupling Interval ◽  
Familial Cardiomyopathy ◽  
Preliminary Study ◽  
Group 2

Abstract Coupling interval (CI), the time (ms) from the onset of a sinus QRS to the onset of the following premature ventricular complex (PVC), and their variability (CIV) might predict mortality and elucidate mechanisms of arrhythmogenesis. There has been limited investigation of CIV in dogs. Therefore, we determined CIV and prematurity index (PI) in three groups of dogs with ventricular arrhythmias that were subject to 24 hour ambulatory electrocardiographic (Holter) monitoring. Dogs in group 1 had presumptive arrhythmogenic right ventricular cardiomyopathy (ARVC), those in group 2 had structural heart disease in which patients with valvular heart disease predominated, and those in group 3 had a dilated cardiomyopathy (DCM) either phenotype or presumed familial cardiomyopathy. In this preliminary study, we did not find significant differences in indices of CIV between groups. Median PI was lower in dogs treated with antiarrhythmic therapy. Severity of cardiac remodeling, except for left atrial to aortic ratio, were not correlated with CIV. It was not possible to determine the mechanism of arrhythmias in ARVC, DCM phenotype or structural heart disease groups and re-entry, triggered activity, and abnormal automaticity are possible etiologies. The effect of antiarrhythmic therapy demonstrated potential drug effect on CIV. Risk for malignant arrhythmias and sudden cardiac death were not examined. A larger study would be needed to determine if differences exist; if present, this would give insight into possible mechanisms and optimal antiarrhythmic therapy.

Sign in / Sign up

Export Citation Format

Share Document